These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 18593771)
1. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. Vesterhus M; Haldorsen IS; Raeder H; Molven A; Njølstad PR J Clin Endocrinol Metab; 2008 Sep; 93(9):3505-9. PubMed ID: 18593771 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3. Vesterhus M; Raeder H; Johansson S; Molven A; Njølstad PR Diabetes Care; 2008 Feb; 31(2):306-10. PubMed ID: 17989309 [TBL] [Abstract][Full Text] [Related]
3. Exocrine pancreatic function in hepatocyte nuclear factor 1β-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Tjora E; Wathle G; Erchinger F; Engjom T; Molven A; Aksnes L; Haldorsen IS; Dimcevski G; Raeder H; Njølstad PR Diabet Med; 2013 Aug; 30(8):946-55. PubMed ID: 23600988 [TBL] [Abstract][Full Text] [Related]
4. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305 [TBL] [Abstract][Full Text] [Related]
7. Lack of pancreatic body and tail in HNF1B mutation carriers. Haldorsen IS; Vesterhus M; Raeder H; Jensen DK; Søvik O; Molven A; Njølstad PR Diabet Med; 2008 Jul; 25(7):782-7. PubMed ID: 18644064 [TBL] [Abstract][Full Text] [Related]
8. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series. Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087 [TBL] [Abstract][Full Text] [Related]
9. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus. Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348 [TBL] [Abstract][Full Text] [Related]
10. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes. Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young. Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507 [TBL] [Abstract][Full Text] [Related]
12. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing. López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Philippe MF; Benabadji S; Barbot-Trystram L; Vadrot D; Boitard C; Larger E Pancreas; 2011 Apr; 40(3):359-63. PubMed ID: 21283038 [TBL] [Abstract][Full Text] [Related]
14. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Ellard S; Colclough K Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892 [TBL] [Abstract][Full Text] [Related]
15. Circulating CD36 is reduced in HNF1A-MODY carriers. Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322 [TBL] [Abstract][Full Text] [Related]
16. Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes. Balamurugan K; Bjørkhaug L; Mahajan S; Kanthimathi S; Njølstad PR; Srinivasan N; Mohan V; Radha V Clin Genet; 2016 Dec; 90(6):486-495. PubMed ID: 26853433 [TBL] [Abstract][Full Text] [Related]
18. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222 [TBL] [Abstract][Full Text] [Related]
19. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations. Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481 [TBL] [Abstract][Full Text] [Related]
20. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)? Karlsson E; Shaat N; Groop L Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]